NCT05341154View on ClinicalTrials.gov

Ketamine Versus Dexmedetomidine for Prevention of Postoperative Delirium

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

May 6, 2023

Study Completion Date

May 6, 2023

Conditions
Emergence Delirium
Interventions
DRUG

Ketamine Hcl 50Mg/Ml Inj

Patients will be given the active comparator or placebo only once right before the induction of anesthesia.

Trial Locations (1)

81511

Huda Fahmy Mahmoud, Aswān

All Listed Sponsors
lead

Huda Fahmy Mahmoud, PhD

OTHER

NCT05341154 - Ketamine Versus Dexmedetomidine for Prevention of Postoperative Delirium | Biotech Hunter | Biotech Hunter